• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小窝蛋白1可防止小鼠因饮食诱导的肝脏脂质积累。

Caveolin1 protects against diet induced hepatic lipid accumulation in mice.

作者信息

Li Meng, Chen Dahua, Huang Haixiu, Wang Jiewei, Wan Xingyong, Xu Chengfu, Li Chunxiao, Ma Han, Yu Chaohui, Li Youming

机构信息

Department of Gastroenterology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

PLoS One. 2017 Jun 1;12(6):e0178748. doi: 10.1371/journal.pone.0178748. eCollection 2017.

DOI:10.1371/journal.pone.0178748
PMID:28570612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5453590/
Abstract

BACKGROUND AND AIM

Caveolin1 (CAV1) is involved in lipid homeostasis and endocytosis, but little is known about the significance of CAV1 in the pathogenesis and development of nonalcoholic fatty liver disease (NAFLD). This study aimed to determine the role of CAV1 in NAFLD.

METHODS

Expression of CAV1 in the in vitro and in vivo models of NAFLD was analyzed. The effects of CAV1 knockdown or overexpression on free fatty acid (FFA)-induced lipid accumulation in L02 cells and AML12 cells were determined. CAV1 knockout (CAV1-KO) mice and their wild-type (WT) littermates were subjected to a high fat diet (HFD) for 4 weeks, and the functional consequences of losing the CAV1 gene and its subsequent molecular mechanisms were also examined.

RESULTS

Noticeably, CAV1 expression was markedly reduced in NAFLD. CAV1 knockdown led to the aggravation of steatosis that was induced by FFA in both L02 cells and AML12 cells, while CAV1 overexpression markedly attenuated lipid accumulation in the cells. Consistent with CAV1 repression in the livers of HFD-induced mice, the CAV1-KO mice exhibited more severe hepatic steatosis upon HFD intake. In addition, increased cholesterol levels and elevated transaminases were detected in the plasma of CAV1-KO mice. The protein expression of SREBP1, a key gene involved in lipogenesis, was augmented following CAV1 suppression in FFA-treated hepatocytes and in the livers of HFD-fed CAV1-KO mice.

CONCLUSIONS

CAV1 serves as an important protective factor in the development of NAFLD by modulating lipid metabolism gene expression.

摘要

背景与目的

小窝蛋白1(CAV1)参与脂质稳态和内吞作用,但关于CAV1在非酒精性脂肪性肝病(NAFLD)发病机制和发展中的意义知之甚少。本研究旨在确定CAV1在NAFLD中的作用。

方法

分析了NAFLD体外和体内模型中CAV1的表达。确定了CAV1基因敲低或过表达对游离脂肪酸(FFA)诱导的L02细胞和AML12细胞脂质积累的影响。对CAV1基因敲除(CAV1-KO)小鼠及其野生型(WT)同窝小鼠进行4周高脂饮食(HFD)喂养,并研究缺失CAV1基因的功能后果及其后续分子机制。

结果

值得注意的是,NAFLD中CAV1表达明显降低。CAV1基因敲低导致L02细胞和AML12细胞中FFA诱导的脂肪变性加重,而CAV1过表达则明显减轻细胞内脂质积累。与HFD诱导小鼠肝脏中CAV1表达受抑制一致,CAV1-KO小鼠在摄入HFD后表现出更严重的肝脂肪变性。此外,在CAV1-KO小鼠血浆中检测到胆固醇水平升高和转氨酶升高。在FFA处理的肝细胞和HFD喂养的CAV1-KO小鼠肝脏中,CAV1受抑制后,参与脂肪生成的关键基因SREBP1的蛋白表达增加。

结论

CAV1通过调节脂质代谢基因表达,在NAFLD的发展中起重要保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/7e1c1c831006/pone.0178748.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/978d787350b2/pone.0178748.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/82f0975cb27a/pone.0178748.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/6fb8ea0e8ac5/pone.0178748.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/35064deaffaa/pone.0178748.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/cd0e1cfd22c4/pone.0178748.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/7e1c1c831006/pone.0178748.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/978d787350b2/pone.0178748.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/82f0975cb27a/pone.0178748.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/6fb8ea0e8ac5/pone.0178748.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/35064deaffaa/pone.0178748.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/cd0e1cfd22c4/pone.0178748.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f759/5453590/7e1c1c831006/pone.0178748.g006.jpg

相似文献

1
Caveolin1 protects against diet induced hepatic lipid accumulation in mice.小窝蛋白1可防止小鼠因饮食诱导的肝脏脂质积累。
PLoS One. 2017 Jun 1;12(6):e0178748. doi: 10.1371/journal.pone.0178748. eCollection 2017.
2
[Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].[利拉鲁肽通过增加AMPK保护高脂饮食且Acrp30沉默的载脂蛋白E基因敲除小鼠免受非酒精性脂肪性肝病的影响]
Zhonghua Gan Zang Bing Za Zhi. 2014 Nov;22(11):849-53. doi: 10.3760/cma.j.issn.1007-3418.2014.11.010.
3
Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway.窖蛋白-1 通过抑制 Akt/mTOR 通路促进自噬来减轻与非酒精性脂肪性肝病相关的脂质积累。
Eur J Pharmacol. 2020 Mar 15;871:172910. doi: 10.1016/j.ejphar.2020.172910. Epub 2020 Jan 9.
4
Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.肝 STAMP2 减轻高脂饮食诱导的肝脂肪变性和胰岛素抵抗。
J Hepatol. 2015 Aug;63(2):477-85. doi: 10.1016/j.jhep.2015.01.025. Epub 2015 Jan 31.
5
Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease.肝细胞窖蛋白-1调节非酒精性脂肪性肝病的代谢基因谱和功能。
Cell Death Dis. 2020 Feb 6;11(2):104. doi: 10.1038/s41419-020-2295-5.
6
Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.肝脂肪变性中异常的miR199a - 5p/小窝蛋白1/过氧化物酶体增殖物激活受体α轴
J Mol Endocrinol. 2014 Dec;53(3):393-403. doi: 10.1530/JME-14-0127. Epub 2014 Oct 13.
7
Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.硫氧还蛋白相互作用蛋白通过 PRMT1 和 PGC-1α 的调控在体外和体内介导肝脂肪生成和炎症。
J Hepatol. 2014 Nov;61(5):1151-7. doi: 10.1016/j.jhep.2014.06.032. Epub 2014 Jul 6.
8
Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance.类固醇生成急性调节蛋白(StAR)过表达可减轻 HFD 诱导的肝脂肪变性和胰岛素抵抗。
Biochim Biophys Acta Mol Basis Dis. 2017 Apr;1863(4):978-990. doi: 10.1016/j.bbadis.2017.01.026. Epub 2017 Jan 30.
9
USP13 ameliorates nonalcoholic fatty liver disease through inhibiting the activation of TAK1.USP13 通过抑制 TAK1 的激活改善非酒精性脂肪性肝病。
J Transl Med. 2024 Jul 20;22(1):671. doi: 10.1186/s12967-024-05465-4.
10
Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice.曲克芦丁通过恢复高脂饮食处理小鼠中烟酰胺腺嘌呤二核苷酸(NAD⁺)耗竭介导的脂联素1信号功能障碍来改善肝脏脂质稳态。
Biochem Pharmacol. 2014 Sep 1;91(1):74-86. doi: 10.1016/j.bcp.2014.07.002. Epub 2014 Jul 12.

引用本文的文献

1
DJ-1 counteracts Caveolin-1-mediated necroptosis to inhibit epithelial barrier dysfunction in colitis.DJ-1可对抗小窝蛋白-1介导的坏死性凋亡,以抑制结肠炎中的上皮屏障功能障碍。
Cell Death Dis. 2025 Aug 29;16(1):657. doi: 10.1038/s41419-025-07989-z.
2
Identification and evaluation of metabolic mRNAs and key miRNAs in colorectal cancer liver metastasis.结直肠癌肝转移中代谢性mRNA和关键miRNA的鉴定与评估
Cancer Cell Int. 2025 Jul 16;25(1):265. doi: 10.1186/s12935-025-03903-x.
3
Nitrosation of CD36 Regulates Endothelial Function and Serum Lipids.

本文引用的文献

1
miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1.微小RNA-29a通过诱导固醇调节元件结合蛋白-1c(SREBP-1c)和小窝蛋白1(CAV1)的表达促进丙型肝炎病毒感染中的脂滴和甘油三酯形成。
J Clin Transl Hepatol. 2016 Dec 28;4(4):293-299. doi: 10.14218/JCTH.2016.00046. Epub 2016 Dec 26.
2
Caveolin-1 Function in Liver Physiology and Disease.窖蛋白-1 在肝脏生理学和疾病中的作用。
Trends Mol Med. 2016 Oct;22(10):889-904. doi: 10.1016/j.molmed.2016.08.007. Epub 2016 Sep 12.
3
Interplay between hepatic mitochondria-associated membranes, lipid metabolism and caveolin-1 in mice.
CD36的亚硝化作用调节内皮功能和血脂。
Arterioscler Thromb Vasc Biol. 2025 Jul;45(7):1067-1086. doi: 10.1161/ATVBAHA.124.321964. Epub 2025 Apr 17.
4
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.胆汁酸激活受体:整合非酒精性脂肪性肝病中的免疫与代谢调节
Liver Res. 2021 Sep 2;5(3):119-141. doi: 10.1016/j.livres.2021.08.003. eCollection 2021 Sep.
5
Caveolin-1 mitigates the advancement of metabolic dysfunction-associated steatotic liver disease by reducing endoplasmic reticulum stress and pyroptosis through the restoration of cholesterol homeostasis.小窝蛋白-1通过恢复胆固醇稳态减轻内质网应激和细胞焦亡,从而缓解代谢功能障碍相关脂肪性肝病的进展。
Int J Biol Sci. 2025 Jan 1;21(2):490-506. doi: 10.7150/ijbs.100794. eCollection 2025.
6
Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism.代谢功能障碍相关脂肪性肝病的发病机制:脂质代谢的重要作用。
J Clin Transl Hepatol. 2024 Sep 28;12(9):815-826. doi: 10.14218/JCTH.2024.00019. Epub 2024 Sep 3.
7
Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury-A Repeated Dose Study in Minipigs for 28 Days.双氯芬酸扰乱生物钟,并通过复杂的串扰加重免疫介导的肝损伤-28 天迷你猪重复剂量研究。
Int J Mol Sci. 2023 Jan 11;24(2):1445. doi: 10.3390/ijms24021445.
8
Adeno-associated virus-based caveolin-1 delivery via different routes for the prevention of cholesterol gallstone formation.腺相关病毒载体通过不同途径递送窖蛋白 1 预防胆固醇结石形成。
Lipids Health Dis. 2022 Oct 27;21(1):109. doi: 10.1186/s12944-022-01718-7.
9
A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease.非酒精性脂肪肝去脂策略的研究进展。
Int J Mol Sci. 2022 Oct 5;23(19):11805. doi: 10.3390/ijms231911805.
10
Serum Caveolin-1 Level is Inversely Associated with Serum Vaspin, Visfatin, and HbA1c in Newly Diagnosed Men with Type-2 Diabetes.血清小窝蛋白-1水平与新诊断的2型糖尿病男性患者的血清内脏脂肪素、内脂素及糖化血红蛋白水平呈负相关。
Rep Biochem Mol Biol. 2022 Jul;11(2):299-309. doi: 10.52547/rbmb.11.2.299.
小鼠肝脏线粒体相关膜、脂质代谢与小窝蛋白-1之间的相互作用
Sci Rep. 2016 Jun 6;6:27351. doi: 10.1038/srep27351.
4
Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.肝脂肪变性中异常的miR199a - 5p/小窝蛋白1/过氧化物酶体增殖物激活受体α轴
J Mol Endocrinol. 2014 Dec;53(3):393-403. doi: 10.1530/JME-14-0127. Epub 2014 Oct 13.
5
Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR/Cas9.通过腺病毒递送CRISPR/Cas9在成年小鼠肝脏中进行高效基因编辑。
FEBS Lett. 2014 Nov 3;588(21):3954-8. doi: 10.1016/j.febslet.2014.09.008. Epub 2014 Sep 19.
6
Sex-dependent expression of caveolin 1 in response to sex steroid hormones is closely associated with development of obesity in rats.小窝蛋白1对性甾体激素反应的性别依赖性表达与大鼠肥胖的发生密切相关。
PLoS One. 2014 Mar 7;9(3):e90918. doi: 10.1371/journal.pone.0090918. eCollection 2014.
7
Caveolin-1 is necessary for hepatic oxidative lipid metabolism: evidence for crosstalk between caveolin-1 and bile acid signaling.窖蛋白-1 对于肝脏的氧化脂质代谢是必需的:窖蛋白-1 与胆汁酸信号之间相互作用的证据。
Cell Rep. 2013 Jul 25;4(2):238-47. doi: 10.1016/j.celrep.2013.06.017. Epub 2013 Jul 11.
8
Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis.窖蛋白-1 可保护 B6129 小鼠抵抗幽门螺杆菌胃炎。
PLoS Pathog. 2013;9(4):e1003251. doi: 10.1371/journal.ppat.1003251. Epub 2013 Apr 11.
9
Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1.与 caveolin-1 缺失相关的线粒体功能改变和代谢灵活性降低。
Cell Metab. 2012 Feb 8;15(2):171-85. doi: 10.1016/j.cmet.2012.01.004.
10
Caveolin-1 orchestrates the balance between glucose and lipid-dependent energy metabolism: implications for liver regeneration.窖蛋白-1 调控葡萄糖和脂质依赖的能量代谢平衡:对肝再生的影响。
Hepatology. 2012 May;55(5):1574-84. doi: 10.1002/hep.24810. Epub 2012 Apr 4.